5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | NEUTRAL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.45▲ | 3.45▲ | 3.45▲ | 3.40▲ | 3.48▼ |
MA10 | 3.48▲ | 3.48▲ | 3.48▲ | 3.35▲ | 3.45▼ |
MA20 | 3.42▲ | 3.41▲ | 3.40▲ | 3.48▼ | 3.10▲ |
MA50 | 3.30▲ | 3.34▲ | 3.36▲ | 3.49▼ | 3.16▲ |
MA100 | 3.45▲ | 3.52▼ | 3.53▼ | 3.11▲ | 3.92▼ |
MA200 | 3.52▼ | 3.53▼ | 3.50▼ | 3.11▲ | 44.54▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.000▼ | 0.004▲ | 0.009▲ | -0.002▼ | 0.049▲ |
RSI | 61.111▲ | 59.325▲ | 58.907▲ | 50.797▲ | 54.808▲ |
STOCH | 35.985 | 35.985 | 45.429 | 57.233 | 59.973 |
WILL %R | -20.455▲ | -20.455▲ | -15.000▲ | -28.302 | -33.103 |
CCI | 28.503 | 28.503 | 40.195 | 58.845 | 22.353 |
Thursday, August 14, 2025 05:21 AM
Q2 2025 Earnings Call Transcript August 13, 2025 PolyPid Ltd. misses on earnings expectations. Reported EPS is $-0.78 EPS, expectations were $-0.53. Operator: Greetings, and welcome to PolyPid’s ...
|
Thursday, August 14, 2025 12:19 AM
PolyPid Ltd (PYPD) reports significant progress in clinical trials and regulatory plans, despite increased R&D and administrative costs.
|
Wednesday, August 13, 2025 04:38 AM
As of June 30, 2025, the Company had cash and cash equivalents and short-term deposits in the amount of $29.5 million, compared to $15.6 million on December 31, 2024. PolyPid expects that its current ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 3.34 | 3.543 | 3.34 | 3.45 | 62,500 |
14/08/25 | 3.50 | 3.59 | 3.34 | 3.43 | 37,500 |
13/08/25 | 3.38 | 3.55 | 3.261 | 3.49 | 97,600 |
12/08/25 | 3.23 | 3.50 | 3.23 | 3.42 | 72,500 |
11/08/25 | 3.24 | 3.42 | 3.14 | 3.23 | 72,100 |
08/08/25 | 3.28 | 3.34 | 3.10 | 3.22 | 79,836 |
07/08/25 | 3.26 | 3.263 | 3.07 | 3.21 | 86,300 |
06/08/25 | 3.36 | 3.60 | 3.15 | 3.26 | 138,000 |
05/08/25 | 3.451 | 3.515 | 3.30 | 3.37 | 145,000 |
04/08/25 | 3.41 | 3.60 | 3.31 | 3.44 | 95,989 |
|
|
||||
|
|
||||
|
|